Intuitive Surgical, Inc. $ISRG Shares Purchased by Brighton Jones LLC

Brighton Jones LLC lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 99.5% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 18,566 shares of the medical equipment provider’s stock after buying an additional 9,258 shares during the quarter. Brighton Jones LLC’s holdings in Intuitive Surgical were worth $7,549,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently bought and sold shares of the company. Bank of America Corp DE lifted its holdings in Intuitive Surgical by 3.3% in the first quarter. Bank of America Corp DE now owns 3,616,973 shares of the medical equipment provider’s stock worth $1,667,388,000 after buying an additional 116,292 shares during the period. Bank of New York Mellon Corp bought a new stake in Intuitive Surgical during the 2nd quarter valued at approximately $1,335,753,000. Amundi grew its holdings in shares of Intuitive Surgical by 8.6% during the 1st quarter. Amundi now owns 2,428,356 shares of the medical equipment provider’s stock worth $1,119,448,000 after acquiring an additional 193,096 shares during the period. Arrowstreet Capital Limited Partnership grew its holdings in shares of Intuitive Surgical by 95.3% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider’s stock worth $970,635,000 after acquiring an additional 1,027,475 shares during the period. Finally, Sumitomo Mitsui Trust Group Inc. grew its holdings in shares of Intuitive Surgical by 10.8% during the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,893,485 shares of the medical equipment provider’s stock worth $769,948,000 after acquiring an additional 184,044 shares during the period. 83.64% of the stock is owned by institutional investors.

Insider Activity

In other news, Director Amy Ladd sold 400 shares of the business’s stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $379.00, for a total value of $151,600.00. Following the sale, the director directly owned 251 shares of the company’s stock, valued at $95,129. The trade was a 61.44% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Craig Barratt sold 1,150 shares of the business’s stock in a transaction that occurred on Friday, October 23rd. The stock was sold at an average price of $443.80, for a total value of $510,370.00. Following the completion of the sale, the director directly owned 1,150 shares in the company, valued at approximately $510,370. This represents a 50.00% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 49,928 shares of company stock valued at $21,917,367. 0.60% of the stock is currently owned by insiders.

Analysts Set New Price Targets

ISRG has been the subject of several research reports. Royal Bank Of Canada decreased their target price on Intuitive Surgical from $575.00 to $550.00 and set an “outperform” rating for the company in a research report on Wednesday, October 21st. BMO Capital Markets restated an “outperform” rating on shares of Intuitive Surgical in a research report on Monday, July 20th. Oppenheimer reaffirmed an “outperform” rating and issued a $500.00 price target on shares of Intuitive Surgical in a research note on Wednesday, October 21st. BTIG Research reaffirmed a “buy” rating and issued a $454.00 price target on shares of Intuitive Surgical in a research note on Wednesday, October 21st. Finally, Citigroup decreased their price objective on Intuitive Surgical from $590.00 to $500.00 and set a “buy” rating for the company in a report on Friday, July 17th. One research analyst has rated the stock with a Strong Buy rating, twenty-three have assigned a Buy rating, five have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $493.54.

Key Headlines Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Da Vinci system placements increased 28% year over year to 546 in the third quarter of 2026, and net placements rose 40%, expanding the installed base and supporting future revenue from instruments and services. Article: ISRG System Placements Rise 28%
• Neutral Sentiment: Analysts caution that the placement jump may have been driven partly by multisystem orders and upgrades, so it does not necessarily signal a broad-based increase in hospital capital spending or guarantee the pace will continue. Article: ISRG System Placements Rise 28%: Is Capital Equipment Demand Rising?
• Neutral Sentiment: Recent Zacks coverage says ISRG is attracting investor attention but, in the information provided, identifies no new fundamental development that would explain a change in the stock’s prospects. Article: ISRG is Attracting Investor Attention
• Negative Sentiment: Directors Gary Guthart and Craig Barratt reported sales of 10,000 and 1,150 shares, respectively. Both transactions were made under pre-arranged Rule 10b5-1 plans, which may lessen their signaling significance, but insider selling can still add a modest sentiment headwind. SEC filing: Gary Guthart transaction SEC filing: Craig Barratt transaction

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG opened at $452.80 on Friday. Intuitive Surgical, Inc. has a 1 year low of $328.57 and a 1 year high of $603.88. The firm has a 50-day moving average of $409.93 and a 200 day moving average of $431.89. The stock has a market cap of $156.96 billion, a P/E ratio of 54.75, a price-to-earnings-growth ratio of 3.12 and a beta of 1.45.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share for the quarter, topping analysts’ consensus estimates of $2.65 by $0.35. The business had revenue of $3.05 billion for the quarter, compared to analysts’ expectations of $2.91 billion. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The business’s revenue was up 21.7% compared to the same quarter last year. During the same quarter in the prior year, the company earned $2.40 earnings per share. Research analysts expect that Intuitive Surgical, Inc. will post 9.37 earnings per share for the current fiscal year.

About Intuitive Surgical